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Six hybrid N-ureidoethylamides of octapeptides in which 
an N-terminal cyclic structure related to enkephalin was 
elongated by a C-terminal fragment of deltorphin were 
synthesized on MBHA resin. The synthetic procedure in-
volved deprotection of Boc groups with HCl/dioxane and 
cleavage of the peptide resin with 45 % TFA in DCM. d-
Lys and d-Orn were incorporated in position 2, and Lys, 
Orn, Dab, or Dap in position 5. The side chains of the 
dibasic amino function were protected with the Fmoc 
group. This protection was removed by treatment with 
55 % piperidine in DMF, and cyclization was achieved 
by treatment with bis-(4-nitrophenyl)carbonate. Using 
various combinations of dibasic amino acids, peptides 
containing a 17-, 18-, 19- or 20-membered ring struc-
ture were obtained. The peptides were tested in the 
guinea-pig ileum (GPI) and mouse vas deferens (MVD) 
assays. Diverse opioid activities were observed, depend-
ing on the size of the ring. Extension of the enkephalin 
sequence at the C-terminus by a deltorphin fragment re-
sulted in a change of receptor selectivity in favor of the 
δ receptor. The conformational propensities of selected 
peptides were determined using the EDMC method in 
conjunction with data derived from NMR experiments 
carried out in water. This approach allowed proper ex-
amination of the dynamical behavior of these small pep-
tides. The results were compared with those obtained 
earlier with corresponding N-(ureidoethyl)pentapeptide 
amides.
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INTRODUCTION
Endogenous opioid peptides, such as enkephalins, 
endorphins, deltorphins, dynorphins and endomorphins 
are involved in regulation of many biological processes, 
among them pain control. However, clinical utility as 
therapeutic analgesics is limited by their susceptibility to 
enzymatic degradation and several side effects. Biological 
activities of opioid peptides are mediated through three 
major opioid receptor types (μ, δ and κ) and the distinct 
structure of a peptide has an impact on the selectivity of 
receptor types and consequently on the activity profile.
The analgesic effect of the most effective therapeutic 
non-peptidic agent, morphine, is mediated through the 
μ opiate receptor. However, its clinical utility is limited 
by the side effects, such as respiratory depression and 
development of tolerance and dependence.
Enkephalins and other δ opiate receptor selective 
drugs share the morphin’s analgesic effect, but have re-
duced negative properties: respiratory depression (Cheng 
et al., 1993; Su et al., 1998) and reveal minimal potential 
for the development of physical dependence (Cowan et 
al., 1988).
 The development of new opioid peptides with in-
creased selectivity for δ opioid receptor seems to be a 
good avenue to obtaining drugs that may produce only 
desired physiological responses. One of the methods 
that could allow reaching this goal is the design of con-
formationally restricted peptides. The most promising 
approach to obtaining a selective agonist is cyclization of 
a linear active peptide which can adopt a conformation 
able to interact preferentially with one receptor. This is 
also expected to increase the enzymatic stability and ac-
tivity of the resulting cyclic peptide.
Peptides can be cyclized through formation of addi-
tional bonds, e.g., disulfide, lactone, lactame or forma-
tion of bridges between two amino-acid residues, e.g., a 
carbonyl bridge or oligomethylene group (Davis, 2003; 
Janecka & Kruszynski, 2005). In several cases incorpo-
ration of cyclized opioid peptides has been shown to 
enhance selectivity for a distinct opioid receptor type. 
Further increase in selectivity of an active and selec-
tive cyclic peptide is also possible as demonstrated by 
replacement of cysteine by β,β-dimethylcysteine in an 
enkephalin analog cyclized by formation of a disulfide 
bridge (Akiyama et al., 1985). 
Attempts to increase selectivity of a cyclic peptide by 
synthesis of chimeric peptides have also been reported: 
-Val-Gly-NH2, which is a C-terminal fragment of del-
torphin address sequence (-Val-Val-Gly-NH2), was add-
ed to the above-mentioned enkephalin analogs cyclized 
by formation of a disulfide bridge between two β,β-
dimethylcysteine residues (Misicka et al., 1994).
Previously we described the synthesis, biological activ-
ity, and conformational analysis of several highly potent 
side-chain-to-side-chain cyclized analogs of enkephalin 
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amides (H-Tyr-Gly-Gly-Phe-Met-NH2) in which Gly2 
and Met5 were replaced by dibasic amino acids and cyclic 
structure was obtained by incorporation of side-chain 
amino groups into urea residue (Pawlak et al., 2001; Filip 
et al., 2005). Using the same synthetic procedure we ob-
tained analogs of an N-terminal segment of deltorphin 
(H-Tyr-Gly-Phe-Asp-) by introduction of dibasic amino 
acids in positions 2 and 4 (Filip et al., 2003). We also 
obtained N-(ureidoethyl)amides of enkephalin related to 
the cyclic amides studied earlier, using a convenient syn-
thetic method developed in this laboratory (Ciszewska et 
al., 2009).
Most peptides of those three series showed very high 
potency both in the guinea-pig ileum (GPI) and mouse 
vas deferens (MVD) assays, which indicated a need to 
modify their structure to obtain more selective opiates. 
Addition of an address sequence of deltorphin (-Val-Val-
Gly-NH2) to the cyclic structure comprising positions 
1–4 resulted in greatly increased δ selectivity. Several 
such peptides were a hundred times more active in the 
MVD assay than in the GPI assay (Zieleniak et al., 2008).
In this work we obtained six hybrid peptides contain-
ing a message sequence of enkephalin, restricted via a 
urea bridge as described above, and a C-terminal address 
of deltorphin. To facilitate the synthesis, the peptides 
were obtained in the form of N-(ureidoethyl)amides.
MATERIALS AND METHODS
Peptide synthesis. General procedure. The p-nitrophe-
noxycarbonyl derivative of Boc-diaminoethane was ob-
tained as described earlier (Wiszniewska et al., 2005). 
This compound (0.401 g, 1.25 mmol) was coupled to 
the MBHA resin (0.25 meq/g, 1 % crosslink, 100–200 
mesh) in DMF at 60 ºC for 48 days. The Boc group 
was removed by treatment with 15 % HCl/dioxane, 
then Boc- amino acids were successively attached using 
N,N′-diisopropylcarbodiimide as a coupling reagent and 
15 %HCl/dioxane for deprotection. The side chain ami-
no function was protected by Fmoc group. The Tyr side 
chain was not protected. The peptidyl-resin was treated 
with 55 % piperidine in DMF with stirring for 50 min 
to remove the Fmoc groups and washed with DMF. 
To a stirred suspension of peptidyl-resin in DMF (200 
ml) bis(p-nitrophenyl)carbonate (0.76 g, 0.25 mmol) was 
added in portions (about 50 % + 25 % + 12.5 % + 12.5 %) 
and stirring was continued for 7 days. DIPEA (0.065 g) 
was gradually added during this reaction. The peptide 
was cleaved off by treatment with 55 % TFA/DCM for 
1 + 20 min. TFA was evaporated under reduced pressure 
and the residue was lyophilized. The yield of the crude 
product was 80–140 mg. The products were purified by 
semi-preparative reversed-phase high performance liq-
uid chromatography using the solvent system: A: 0.05 % 
TFA in water, B: 60 % MeCN in A on a Vydac column 
(Nucleosil 300, C18, 5 μm, 10 × 250 mm), flow rate of 2 
ml/min, gradient B (15 % in 15 min, 15–30 % in 15 min, 
30–45 % in 40 min). Fractions were analyzed on a Vertex 
Nucleosil-100 C18 column (4 mm × 250 mm, 5 μm), flow 
rate 1 ml/min. For analysis, a linear gradient of 20–80 % 
B was used (1 ml/min, t = 15 min), detection at 220 nm. 
Fractions were pooled for maximum purity rather than 
yield. Homogeneous fractions containing one peak were 
combined and lyophilized. Structures were confirmed by 
ESI-MS mass spectrometry (Finningan MAT 95S spec-
trometer, Bremen, Germany). 1: M calcd. 965.5, obtained 
988.6 (M+Na+); 2: M calcld. 979.5, obtained 1002.6 
(M+Na+); 3: M calcld 993.4, obtained 1016.6 (M + Na+); 
4: M calcld. 951.3, obtained 974.5 (M+Na+); 5: M calcld. 
965.5, obtained 988.6 (M+Na+); 6: M calcd. 993.4 ob-
tained 1016.4 (M+Na+). The structures of the peptides 
are presented in Fig. 1.
Bioassays. The guinea-pig ileum (GPI) assay (μ re-
ceptor-representative) (Paton, 1957) and the mouse vas 
deferens (MVD) assay (δ receptor-representative) (Hend-
erson et al., 1972) were carried out as reported in de-
tail elsewhere (Schiller et al., 1978; DiMaio & Schiller, 
1980). A log dose-response curve was determined with 
[Leu5]-enkephalin as a standard for each ileum and vas 
preparation and the IC50 values of the compounds being 
tested were normalized according to a published proce-
dure (Waterfield et al., 1979). The results are presented 
in Table 1.
NMR spectroscopy and theoretical analysis. The 
methodology used for generation and selection of con-
formations was previously described for oxytocin and 
arginine-vasopressin (Liwo et al., 1996). It was applied by 
us to one of the opioid peptides and described in de-
tails in this journal (Sidor et al., 1999) and by others to 
a number of compounds (Cohen et al., 2002; Masman 
et al., 2006; 2008). Subsequently we used this method-
ology with success in several studies of different opi-
oid analogs (Pawlak et al., 2001; Filip et al., 2003; 2005; 
Ciszewska et al., 2009). In this paper NMR spectra of 
peptides 2, 3 and 4, which were sufficiently soluble in 
water, were recorded on a Varian INOVA 400 MHz 
and/or a Varian Unity PLUS 500 MHz spectrometer at 
25 °C in H2O/D2O (9 : 1, v/v). For 1D proton spectra 
16k points were collected and a spectral width of 6 kHz 
was used. 2D experiments were measured collecting 2k 
points using 4.5 kHz spectral width in the proton direc-
tion and 256-point increments in the F1 direction. The 
same spectral width was applied in the F1 direction in 
homo-nuclear 2D spectra, whereas a width of 25 kHz 
and 2 kHz for carbon and for nitrogen, respectively, was 
used for hetero-nuclear correlations. A mixing time of 
0.08 s was used in TOCSY measurements and 0.25 s in 
ROESY experiments. DSS was used as a reference exter-
nal standard for proton, carbon and nitrogen dimensions 
(Wishart et al., 1995). Chemical shifts were assigned us-
ing TOCSY, COSY, HSQC [15N, 1H], and HSQC [13C, 
1H] techniques (Aue et al., 1976; Braunschweiler & Ernst, 
1983; Bothner-By et al., 1984; Bax & Davis, 1985; Bax & 
Freeman, 1985; Palmer III et. al., 1991; Kay et al., 1992) 
and they are available in Supplementary Materials at 
www.actabp.pl (Table 1S and 2S). 3JHaHN couplings were 
obtained from 1D 1H spectra and temperature coeffi-
cients were determined with 1D 1H spectra recorded at: 
6.8, 11.0, 15.5, 19.1 and 25.0 ºC (see Table 3S in Supple-
mentary Materials). Cross-peak volume calculations were 
done with the SPARKY program (www.cgl.ucsf.edu/
home/sparky) using data from the ROESY spectra and 
are available in Supplementary Materials (Tables 4S, 5S 
and 6S).
Structures of each peptide were calculated using the 
EDMC method described by (Liwo et al., 1996), e.g., for 
each peptide starting from a conformation with random 
geometry its energy was minimized with the ECEPP/3 
force field (Nemethy et al., 1992) and surface model 
SFROPT (Vila et al., 1991). Thus, the total conforma-
tional energy included a sum of terms: electrostatic, non-
bonding, hydrogen-bond, torsional and terms accounting 
for the entropy for loop closing and solvation. The f 
and y angels of the resulting geometry were further per-
turbed using the Monte Carlo method (Li & Scheraga, 
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1987) and after energy minimization the obtained con-
formation was compared with the previous one and ac-
cepted or discarded using a geometry and/or energy cri-
terion. If the conformation was accepted the procedure 
was repeated. 
The ensemble of resulting structures for each peptide 
was clustered into families using the program CLUST 
(Spath, 1980). Finally, theoretical NOESY spectra were 
generated for each family of structures with the program 
MORASS (Meadows, 1994) and statistical weights for 
each conformation were obtained by fitting a linear com-
bination of generated spectra to the experimental data 
using the Marquardt method (Marquardt, 1963). 
RESULTS AND DISCUSSION
The synthesis was performed using a method based 
on the observation that N-ureidoethyl units could be 
obtained in the synthesis on MBHA resin by reaction 
of the resin with p-nitrophenyl carbonate of Boc-eth-
ylenediamine and that the aminoethylurea unit formed 
was stable during treatment with HCl/dioxane used for 
removal of the Boc group (Wiszniewska et al., 2005). 
d-Lys or d-Orn were incorporated in position 2, and 
Lys, Orn, Dab or Dap in position 5 of the peptide se-
quence using Boc-protected derivatives in the α-amino 
group and Fmoc protection at the side chain amino 
group. After removal of the Fmoc group by treatment 
with 55 % piperidine in DMF and cyclization in a reac-
tion with bis-(4-nitrophenyl)carbonate the resulting pep-
tide was cleaved from the resin by treatment with 45 % 
TFA in DCM. The products were purified using semi-
preparative RP-HPLC. Higher amounts of side products 
in crude products were observed than for similar synthe-
ses in which cyclization was performed in solution (Paw-
lak et al., 1997; Filip et al., 2003). The increased amount 
of side-products may be due to formation of a carbonyl 
bridge between two peptide chains. In cyclization in so-
lution, this problem was overcome by strong dilution of 
the reaction mixture. Fortunately, using semi-preparative 
HPLC, we were able to isolate the desired products. All 
samples for biological studies and NMR measurements 
were free of any contamination, as judged from analyti-
cal HPLC and MS spectra. The chemical formulas of the 
peptides are presented in Fig. 1. In vitro opioid activity 
profiles of the peptides were determined using the GPI 
and MVD assays (Table 1). The peptides were found to 
be agonists in both assays. The activities of the peptides 
varied depending on the size of the ring. The most ac-
tive was peptide 1 in which an 18-membered ring was 
formed by incorporation of side-chain amino groups of 
d-Lys and Dap. It should be recalled that among amides 
of cyclic enkephalin the most active peptide contained 
the same ring (Pawlak et al., 2001). It can be seen that 
the activity of the peptides is high in the MVD assay 
and relatively lower in the GPI assay.
Since peptide 1 is the most δ-selective agonist in this 
series and deserves to be studied in vivo, it is reasonable 
to compare (see Table 2) the selectivity of all peptides 
studied earlier containing the cyclic structure formed by 
incorporation of side chain amino groups of d-Lys and 
l-Dap: the GPI/MVD ratios of amide of cyclo[Nε,Nδ 
-carbonyl-d-Lys2,Dap5 ]enkephalin and N-(ureidoethyl)
amide of cyclo[Nε,Nδ-carbonyl-d-Lys2,Dap5]enkephalin 
were 0.33 (Pawlak et al., 1997) and 1.09 (Ciszewska et al., 
2009), respectively, and in the case of the hybrid peptide 
1 it was 6.97. This shift in selectivity in favor of δ recep-
tors seems to be important in view of our recent finding 
(Kotlińska et al., 2009) that even amide of cyclo[Nε,Nδ 
-carbonyl-d-Lys2,Dap5]enkephalin, which is highly potent 
both in GPI and MVD assays, in vivo studies, with the 
use of selective opioid receptor antagonists, induced an-
tinociception predominantly through opioid δ receptors.
These results clearly indicate that the increase of se-
lectivity in favor of the δ receptor was achieved by a 
decrease in the affinity of these peptides for the μ re-
ceptor, whereas the δ receptor affinity was more or less 
unchanged. These results show that in this case the role 
of the address is different from what was expected on the 
basis of the message-address concept, insofar as addition of 
the address sequence did not increase the affinity for the 
δ receptor. 
In our previous studies on deltorphin analogs we ob-
served that elongation of the cyclic N-terminal segment 
(Filip et al., 2003; Zieleniak et al., 2008) with Val-Val-Gly, 
Figure 1. Structural formula of peptides: 
1 (d-Lys2 , Dap5; m = 4, n = 1); 2 (d-Lys2, Dab5; m = 4, n = 2); 3 (d-Lys2, 
Orn5 ; m = 4, n = 3); 4 (d-Orn2 , Dap5; m = 3, n = 1); 5 (d-Orn2, Dab5; 
m = 3,n = 2); 6 (d-Orn2, Lys5; m = 3, n = 4)
Table 1. GPI and MVD assays of cyclic hybrid peptides
PEPTIDE GPI MVD GPI/MVD
No. Ring size d-Daa2 Daa5 IC50 [nM] Rel. potency IC50 [nM]a Rel. potency IC50 ratio
1 18 Lys Dap 12.9 ± 1 19.0 ± 2 1.85 ± 0.1 6.15 ± 0.45 6.97
2 19 Lys Dab 47.5 ± 5   5.18 ± 0.5 16.9 ± 0.5 0.675 ± 0.019 2.81
3 20 Lys Orn 30.8 ± 1   7.98 ± 0.4 4.18 ± 5 2.73 ± 0.034 7.37
4 17 Orn Dap 76.9 ± 3   3.20 ± 0.1 18.5 ± 2 0.617 ± 0.058 4.16
5 18 Orn Dab 72.1 ± 6   3.41 ± 0.3 20.5 ± 4 0.555 ± 0.109 3.52
6 20 Orn Lys 71.3 ± 3   3.45 ± 0.2 14.5 ± 1 0.788 ± 0.078 4.92
[Leu5]enkephalin 246 ± 39 1 11.4 ± 1.1 1 21.6
aMean of 3–6 determinations ± S.E.M.
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to obtain the full sequence of deltorphin, also resulted 
in an increase in selectivity in favor of the δ receptor. 
This was not only due to a decrease in activity at the μ 
receptor but also to an increase of the activity at the δ 
receptor.
It seems that at least in the cases presented in this 
work, the use of the term modulator rather than the com-
monly used term address may be more appropriate for 
the description of a peptide segment which upon addi-
tion to a biologically active peptide changes the receptor 
selectivity.
 For a better description and understanding of the bi-
ological results at the molecular level the NMR/EDMC 
method was employed (Sidor et al., 1999). Temperature 
coefficients of amide protons obtained from NMR spec-
tra of peptides 2, 3 and 4 are rather high (Table 3S). 
Relatively lower values were observed only for amide 
protons of the Daa5 residues, similar to what was ob-
served for other opioid peptide analogs (Ciszewska et 
al., 2009; Zieleniak et al., 2008). This suggests that the 
amide protons are not engaged in intramolecular hydro-
gen bonding. 
The ensembles of conformations generated and ac-
cepted in the EDMC procedure for each peptide are 
listed in Table 7S in Supplementary Materials. They 
were clustered into families using an energy threshold 
of 20 kcal/mol and an r.m.s.d. of 0.15 Å as separa-
tion criteria. Numbers of the families are also given in 
Table 7S. For representatives of each family, NOESY 
spectra were generated assuming a mixing time of 0.2 
s and applying a correlation time of 0.45 ns. The Mar-
quardt convergence criterion value of 10–5 was used 
in calculations of statistical weights of conformations. 
The conformers obtained for peptides 2, 3 and 4 us-
ing the EDMC/NMR method are presented as their 
VMD (Humphrey et al., 1996) drawings in Fig. 2 and 
corresponding selected torsional angles are listed in 
Table 3. 
Inspection of the data presented in Table 3 reveals a 
large diversity of conformations of the peptides. Their 
geometries and populations differ significantly. In each 
case several well populated conformers with substantially 
varying distances between the aromatic rings of Phe1 and 
Tyr4 were calculated. 
A comparison of the r.m.s.d. values calculated for 
conformers of these peptides and those obtained ear-
lier for their shorter analogs (Ciszewska et al., 2009) in-
dicates that the flexibility of the main rings is similar. 
The r.m.s.d. values were calculated using the carbon 
and nitrogen atoms of the main ring for 2, 3 and 4, 
yielding values of 0.68 Å, 0.80 Å and 0.46 Å, respec-
tively, while the r.m.s.d. values reported for the shorter 
analogs were 0.75 Å , 0.74 Å and 0.51 Å, respectively. 
The r.m.s.d. values calculated after superposition in 
the peptide segment situated between the Tyr and Phe 
residues were 0.40 for 2, 0.45 for 3 and 0.27 Å for 4, 
which suggests decreased conformational diversity as 
compared with the whole ring. This propensity of the 
main ring is common for all types of the peptides ana-
lyzed by us earlier (Pawlak et al., 2001; Filip et al., 2005; 
Ciszewska et al., 2009). 
The r.m.s.d. values calculated using all heavy atoms 
of all residues were 3.73 for 2, 2.73 for 3 and 2.83 Å 
for 4, which indicates a rather high conformational 
freedom of these peptides. This opens the possibility 
for additional intramolecular interactions. In fact, for 
all three peptides NOE contacts were observed be-
tween the ring protons of Phe4 and the CH3 groups of 
Val6. In addition, visual inspection of the VMD draw-
ings of all calculated conformers shown in Fig. 2 re-
veals that the conformers of peptide 3 are relatively 
compact. This is in agreement with the NOE contacts 
between γCH3 (Val7) and ring (Tyr1) protons observed 
in the spectra of this peptide. It may also be noticed 
that for a large set of conformers of peptide 4 their C-
Table 2. GPI/MVD ratio of enkephalin N-(ureidoethyl)amides 
(Ciszewska et al., 2009) and enkephalin/deltorphin hybrid N-
(ureidoethyl)amides (this work)
Amino acids in 
positions 2 and 4
Enkephalin ureido-
ethylamides
Enkephalin/deltorphin 
hybrid ureidoethyl-
amides
d-Lys, Dap 1.97/1.81 (= 1.09) 12.9/1.85 (= 6.97)
d-Lys, Dab 5.55/6.00 (= 0.92) 47.5/16.9 (= 2.81)
d-Lys, Orn 18.1/22.7 (= 0.79) 30.8/4.18 (= 7.36)
d-Orn, Dap 11.3/14.1 (= 0.80) 76.9/18.5 (= 4.16)
d-Orn, Dab 3.36/11.6 (= 0.29) 72.1/20.5 (= 3.53)
d-Orn, Lys 16.1/28.2 (= 0.57) 71.3/14.5 (= 4.92)
Mean value 9.40/14.1 (= 0.64) 51.9/12.6 (= 4.12)
Figure 2. VMD drawings (Humphrey et al., 1996) of the most 
populated (above 3 %) EDMC/NMR calculated conformations of 
peptides 2, 3 and 4
The structures are superimposed using C and N atoms of the main 
ring
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terminal segments are directed towards their main ring. 
These close contacts indicate the presence of additional 
intramolecular interactions involving aromatic rings and 
in consequence may have an impact on the possibility 
of interactions between these rings.
In spite of the differences in distances between the 
aromatic rings it seems reasonable to assume that these 
conformations are flexible enough to adopt a conforma-
tion permitting interaction with the opioid receptor to in-
duce a biological effect. The similar results for enkepha-
lin-deltorphin hybrids and corresponding enkephalins in 
the MVD assay support this suggestion.
CONCLUSIONS
The synthesis of N-(ureidoethyl)amides of cyclic 
enkephalin-deltorphin hybrids was carried out using the 
method described earlier (Ciszewska et al., 2009). The 
peptides differed from cyclic enkephalin N-(ureidoethyl) 
amides reported 
earlier in that the 
amino acid chain 
was elongated C-
terminally with 
the Val-Val-Gly 
sequence, the ad-
dress sequence of 
deltorphin respon-
sible for its high 
affinity for δ re-
ceptors (Charpen-
tier et al., 1991). 
It should be 
noted that the in-
creased selectiv-
ity for δ receptors 
was mainly result 
of decreased activ-
ity for μ receptors. 
The activity in the 
MVD assay of N-
ureidoethylamides 
of cyclic enkepha-
lins and enkeph-
a l i n - d e l t o r p h i n 
hybrids was simi-
lar. Since, in most 
cases, increased 
selectivity towards 
δ receptors was 
obtained as a re-
sult of a decrease 
of the affinity for 
μ receptors, but 
not an increase 
towards δ recep-
tors, it would be 
reasonable to use 
the term modulator 
instead of address 
for a sequence 
that changes the 
receptor selectivity 
ratio.
S t a t i s t i c a l 
weights of confor-
mations for three 
of the six peptides sufficiently soluble in water to permit 
the recording of NMR spectra were obtained in a global 
conformational search using the EDMC method in com-
bination with experimental NOE parameters. NOE con-
tacts for all three peptides between their ring protons of 
Phe4 and the CH3 groups of Val6 and for peptide 3 be-
tween its ring protons of Tyr1 and the γCH3 group of 
Val7 were observed. This finding indicates that a sequence 
added to a message, or to a sequence containing the mes-
sage, is able to introduce additional intra-molecular interac-
tions between the message and the rest of the molecule. In 
the present studies the additional peptide chain interacting 
with the message restricted by ring formation had no effect 
on the results of the MVD assay.
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